# Safety and dose modification for patients receiving niraparib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-dose-modification-for-patients-receiving-niraparib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jonathan S. Berek,Ursula A. Matulonis,Ulla Peen,Prafull Ghatage,Sven Mahner,Andrés Redondo,Anne Lesoin,Nicoletta Colombo,Ignace Vergote,Ora Rosengarten,Jonathan A. Ledermann,Mario Javier Pineda,Susan Ellard,Jalid Sehouli,Antonio González-Martı́n,Dominique Berton-Rigaud,Radosław Mądry,Alexander Reinthaller,Sebastien Hazard,Wenwen Guo,Mansoor R. Mirza |
| Citations | 188 |
| DOI | 10.1093/annonc/mdy181 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1093/annonc/mdy181 |
| OpenAlex ID | https://openalex.org/W2804717005 |
| PMID | 29767688 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Sven Mahner](https://scholariq.org/researchers/sven-mahner/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.